万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant protein
- 亚型:
IgG1
- 形态:
Liquid
- 克隆性:
Mouse monoclonal Antibody
- 标记物:
Non-conjugated
- 适应物种:
Human
- 库存:
现货
- 供应商:
华安生物
- 宿主:
Mouse
- 应用范围:
WB, IHC-P
- 浓度:
2 mg/mL.
- 抗体名:
SIRT7
- 规格:
50μl/100μl
| 规格: | 50μl | 产品价格: | ¥1125.0 |
|---|---|---|---|
| 规格: | 100μl | 产品价格: | ¥1875.0 |
Sirtuins (SIRT1-7) are human homologs of the yeast Sir2 (silent information regulator-2) protein and are divided into four main classes: SIRT1-3 are class I, SIRT4 is class II, SIRT5 is class III and SIRT6-7 are class IV. In S. cerevisiae, Sir2 deacetylates histones in an NAD-dependent manner, which regulates silencing at the telomeric, rDNA (ribosomal DNA) and silent mating-type loci. The human SIRT proteins are NAD-dependent deacetylases that act as intracellular regulators and are thought to have ribosyltransferase activity. SIRT7 (NAD-dependent deacetylase sirtuin-7), also known as SIR2L7, is a member of the class IV sirtuin family and is localized to the nucleolus. Expressed throughout the body, SIRT7 associates with rDNA genes where it interacts with histones and acts as a positive regulator of RNA polymerase I (Pol I). SIRT7 is a probable NAD-dependent deacetylase whose expression is upregulated in thyroid carcinoma cells. Overexpression of SIRT7 increases Pol I-mediated transcription, thereby speeding cell growth and contributing to the development of cancer. Two isoforms exist due to alternative splicing events.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
粒细胞的扩增,可引发小叶乳腺癌 GEM 模型的自发性转移形成,导致 GEM 移植模型的自发转移疾病。GEM 模型在揭示相关基因参与抑制肿瘤转移机制方面也发挥了重要作用。最近,刘宝华课题组应用 Tet-ON 可诱导 Sirt7 表达的 GEM 模型,揭示了 Sirt7 抑制原发胰腺癌转移作用机制,该研究结果证实,由 Dox 诱导表达的 Sirt7 具有明显抑制 MMTV-PyMT 小鼠乳腺肿瘤肺转移的作用,且其作用机制是通过调节 TGF-β信号通路实现的。因此,GEM 模型在揭示肿瘤转移复杂性,挑战当下普遍
技术资料暂无技术资料 索取技术资料
SIRT7
¥1125 - 1875








